Renal protection has been observed in models of acute kidney injury, with improved function markers and reduced tissue damage
The change would remove semaglutide (the ingredient in Novo Nordisks Ozempic and Wegovy), tirzepatide (Eli Lillys Mounjaro and Zepbound), and liraglutide (Novos Victoza and Saxenda)
Many lawsuits allege the risks of NAION injuries were not adequately disclosed before treatment began, preventing patients from making fully informed decisions

Appetite Suppression Timeline Week 1: Strong appetite suppression continues Week 2: Gradual return of normal appetite Week 3: Appetite approaching baseline levels Week 4+: Full return to pre-treatment appetite patterns Weight Loss Maintenance Weeks 1-2: Continued weight loss momentum Weeks 3-4: Weight loss plateau or slight regain Month 2+: Risk of significant weight regain without lifestyle intervention Blood Sugar Control (Diabetic Patients) Week 1: Maintained glucose control Week 2: Gradual increase in blood sugar levels Weeks 3-4: Return to pre-treatment glucose patterns Month 2+: May require alternative diabetes management Cardiovascular Benefits Weeks 1-4: Maintained improvements in blood pressure and circulation Months 2-3: Gradual return toward baseline cardiovascular metrics If you want to plan a safe transition or keep progress steady, small timing and tracking choices matter more than most people assume

They work with your bodys natural processes and are an accessible alternative to traditional hormone therapy
"Food-Drug Interactions: The Case of Glutathione." Nutrients, 11(8), 1820